+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

In Vitro Diagnostics Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

  • PDF Icon

    Report

  • 132 Pages
  • August 2024
  • Region: Global
  • IHR Insights
  • ID: 5995345
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

This report provides an extensive analysis of the in vitro diagnostics (IVD) market from 2020 to 2030. The report includes detailed insights into key trends, drivers, challenges, and opportunities affecting the market. It offers a comprehensive examination of market dynamics, competitive landscape, and regional variations, providing valuable information for stakeholders to make informed decisions and strategies for growth.

Market Dynamics:

1. Key Market Drivers:

  • Technological Advancements: Innovations in IVD technologies, such as automated systems and advanced reagents, are enhancing diagnostic accuracy and efficiency.
  • Increasing Prevalence of Chronic Diseases: Rising incidence of chronic diseases, including cancer, diabetes, and cardiovascular conditions, is driving demand for IVD solutions.
  • Growing Demand for Personalized Medicine: The shift towards personalized medicine and targeted therapies is increasing the need for advanced diagnostic tools and technologies.

2. Key Market Challenges:

  • High Costs of Advanced Technologies: The cost of sophisticated IVD instruments and reagents can be a barrier to adoption, particularly in low-resource settings.
  • Regulatory Compliance: Navigating complex regulatory requirements for IVD products can be challenging for market participants.
  • Need for Skilled Personnel: The complexity of IVD technologies requires skilled professionals for operation and interpretation.

Market Trends:

  • Integration of Automation and AI: The use of automation and artificial intelligence (AI) in IVD is improving diagnostic workflows and accuracy.
  • Expansion of Molecular Diagnostics: The growing application of molecular diagnostics in disease detection and personalized medicine is a significant trend.

Market Size Estimation

The global in vitro diagnostics market is projected to reach USD 65 billion by 2030, growing at a CAGR of 7% from 2024 to 2030. This growth is driven by technological advancements, increasing disease prevalence, and a rising focus on personalized medicine.

Market Segmentation:

1. By Product:

  • Instruments: Includes diagnostic machines and analyzers for various tests.
  • Reagents: Covers test reagents and consumables used in IVD.
  • Consumables: Includes items such as sample tubes and other disposable products.
  • Software: Involves diagnostic software and data management tools.

2. By Technology:

  • Immunoassays: Techniques for detecting and quantifying specific antibodies or antigens.
  • Molecular Diagnostics: Includes PCR, NGS, and other molecular techniques for disease detection and monitoring.
  • Hematology: Diagnostics related to blood disorders and conditions.
  • Clinical Chemistry: Tests for analyzing chemical components in biological samples.
  • Others: Includes additional diagnostic technologies and methods.

3. By Application:

  • Disease Diagnosis: Diagnostics for various diseases, including chronic, infectious, and genetic disorders.
  • Pregnancy and Fertility Testing: Tests related to reproductive health and fertility.
  • Drug Development: Diagnostics used in drug discovery and development processes.
  • Others: Includes other applications such as health monitoring and wellness testing.

4. By End-User:

  • Hospitals: Utilize IVD solutions for patient care and disease management.
  • Diagnostic Laboratories: Specialized facilities providing diagnostic testing services.
  • Research Institutes: Institutions involved in research and development related to IVD.
  • Others: Includes academic institutions, public health organizations, and medical centers.

5. By Region:

  • North America: Leading in market size due to advanced healthcare infrastructure and high investment in research and technology.
  • Europe: Significant growth driven by technological advancements and regulatory support.
  • Asia Pacific: High growth potential due to increasing healthcare access and rising disease prevalence.
  • Latin America: Steady growth influenced by improving diagnostic capabilities and healthcare investments.
  • Middle East and Africa: Growth driven by expanding healthcare infrastructure and increased focus on diagnostic solutions.

Competitive Landscape

Key players in the in vitro diagnostics market include:

  • Roche Diagnostics: Provides a broad range of IVD instruments and reagents.
  • Thermo Fisher Scientific: Offers advanced IVD technologies and solutions.
  • Abbott Laboratories: Known for its IVD instruments and diagnostic products.
  • Siemens Healthineers: Specializes in comprehensive IVD solutions and technologies.
  • Danaher Corporation: Offers a range of diagnostic products and solutions for various applications.

Market Forecast

The in vitro diagnostics market is expected to grow significantly, driven by technological advancements, increasing disease prevalence, and a growing focus on personalized medicine. The integration of automation and AI and the expansion of molecular diagnostics are expected to contribute to market growth.

Regulatory Framework

The market operates under stringent regulatory oversight from organizations such as the FDA in the United States and the EMA in Europe, ensuring the safety, efficacy, and quality of IVD products.

Customer Landscape

The market serves a diverse customer base, including hospitals, diagnostic laboratories, research institutes, and academic institutions. Each segment has specific needs and requirements for IVD solutions.

Regional Analysis

North America leads the market due to its advanced healthcare infrastructure, while Asia Pacific is expected to experience the highest growth rate due to increasing healthcare access and rising disease prevalence.

Table of Contents

1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Segmentation
2.3. Research Methodology
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Global in Vitro Diagnostics Market, by Product
4.1. Instruments
4.2. Reagents
4.3. Software
4.4. Others
5. Global in Vitro Diagnostics Market, by Technology
5.1. Molecular Diagnostics
5.2. Immunoassays
5.3. Clinical Chemistry
5.4. Hematology
5.5. Others
6. Global in Vitro Diagnostics Market, by Application
6.1. Oncology
6.2. Infectious Diseases
6.3. Diabetes
6.4. Cardiovascular Diseases
6.5. Others
7. Global in Vitro Diagnostics Market, by End-User
7.1. Hospitals
7.2. Diagnostic Laboratories
7.3. Research Institutions
7.4. Others
8. Global in Vitro Diagnostics Market, by Region
8.1. North America
8.1.1. United States
8.1.2. Canada
8.1.3. Mexico
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Netherlands
8.2.7. Switzerland
8.2.8. Sweden
8.2.9. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. South Korea
8.3.5. Australia
8.3.6. Singapore
8.3.7. Malaysia
8.3.8. Thailand
8.3.9. Vietnam
8.3.10. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Argentina
8.4.3. Rest of Latin America
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. South Africa
8.5.3. Rest of Middle East and Africa
9. Competitive Landscape
9.1. Market Share Analysis
9.2. Company Profiles
9.2.1. Roche Holding AG
9.2.2. Thermo Fisher Scientific Inc.
9.2.3. Abbott Laboratories
9.2.4. Siemens Healthineers
9.2.5. Danaher Corporation
9.2.6. Bio-Rad Laboratories, Inc.
9.2.7. QIAGEN N.V.
9.2.8. Hologic, Inc.
9.2.9. Illumina, Inc.
9.2.10. Sysmex Corporation
10. Conclusion and Future Outlook11. Appendix
List of Tables
Table 1: Global in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 2: Global in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 3: Global in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 4: Global in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 5: North America in Vitro Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 6: United States in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 7: United States in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 8: United States in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 9: United States in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 10: Canada in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 11: Canada in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 12: Canada in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 13: Canada in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 14: Mexico in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 15: Mexico in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 16: Mexico in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 17: Mexico in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 18: Europe in Vitro Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 19: Germany in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 20: Germany in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 21: Germany in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 22: Germany in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 23: United Kingdom in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 24: United Kingdom in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 25: United Kingdom in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 26: United Kingdom in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 27: France in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 28: France in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 29: France in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 30: France in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 31: Italy in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 32: Italy in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 33: Italy in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 34: Italy in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 35: Spain in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 36: Spain in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 37: Spain in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 38: Spain in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 39: Russia in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 40: Russia in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 41: Russia in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 42: Russia in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 43: Rest of Europe in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 44: Rest of Europe in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 45: Rest of Europe in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 46: Rest of Europe in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 47: Asia Pacific in Vitro Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 48: China in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 49: China in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 50: China in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 51: China in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 52: Japan in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 53: Japan in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 54: Japan in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 55: Japan in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 56: India in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 57: India in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 58: India in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 59: India in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 60: Australia in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 61: Australia in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 62: Australia in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 63: Australia in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 64: South Korea in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 65: South Korea in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 66: South Korea in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 67: South Korea in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 68: ASEAN in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 69: ASEAN in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 70: ASEAN in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 71: ASEAN in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 72: Rest of Asia-Pacific in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 73: Rest of Asia-Pacific in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 74: Rest of Asia-Pacific in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 75: Rest of Asia-Pacific in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 76: MEA in Vitro Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 77: Turkey in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 78: Turkey in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 79: Turkey in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 80: Turkey in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 81: Saudi Arabia in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 82: Saudi Arabia in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 83: Saudi Arabia in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 84: Saudi Arabia in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 85: UAE in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 86: UAE in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 87: UAE in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 88: UAE in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 89: South Africa in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 90: South Africa in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 91: South Africa in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 92: South Africa in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 93: Rest of MEA in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 94: Rest of MEA in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 95: Rest of MEA in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 96: Rest of MEA in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 97: South America in Vitro Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 98: Brazil in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 99: Brazil in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 100: Brazil in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 101: Brazil in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 102: Argentina in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 103: Argentina in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 104: Argentina in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 105: Argentina in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 106: Rest of South America in Vitro Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 107: Rest of South America in Vitro Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 108: Rest of South America in Vitro Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 109: Rest of South America in Vitro Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 110: Company Regional Footprint
Table 111: Company Industry Footprint
List of Figures
Figure 1: Global in Vitro Diagnostics Market Segments
Figure 2: Research Timelines
Figure 3: Data Triangulation Method
Figure 4: Market Research Flow
Figure 5: Data Sources
Figure 6: Executive Summary
Figure 7: Global in Vitro Diagnostics Market Estimates and Forecast (USD Million), 2022-2031
Figure 8: Global in Vitro Diagnostics Market Absolute Market Opportunity
Figure 9: Global in Vitro Diagnostics Market Attractiveness Analysis, by Region
Figure 10: Global in Vitro Diagnostics Market Attractiveness Analysis, by Product
Figure 11: Global in Vitro Diagnostics Market Attractiveness Analysis, by Technology
Figure 12: Global in Vitro Diagnostics Market Attractiveness Analysis, by Application
Figure 13: Global in Vitro Diagnostics Market Attractiveness Analysis, by End-User
Figure 14: Global in Vitro Diagnostics Market Geographical Analysis, 2024-2031
Figure 15: Global in Vitro Diagnostics Market, by Product (USD Million)
Figure 16: Global in Vitro Diagnostics Market, by Technology (USD Million)
Figure 17: Global in Vitro Diagnostics Market, by Application (USD Million)
Figure 18: Global in Vitro Diagnostics Market, by End-User (USD Million)
Figure 19: Future Market Opportunities
Figure 20: Global in Vitro Diagnostics Market Outlook
Figure 21: Porter's Five Forces Analysis
Figure 22: Global in Vitro Diagnostics Market, by Product
Figure 23: Global in Vitro Diagnostics Market Basis Point Share (BPS) Analysis, by Product
Figure 24: Global in Vitro Diagnostics Market, by Technology
Figure 25: Global in Vitro Diagnostics Market Basis Point Share (BPS) Analysis, by Technology
Figure 26: Global in Vitro Diagnostics Market, by Application
Figure 27: Global in Vitro Diagnostics Market Basis Point Share (BPS) Analysis, by Application
Figure 28: Global in Vitro Diagnostics Market, by End-User
Figure 29: Global in Vitro Diagnostics Market Basis Point Share (BPS) Analysis, by End-User
Figure 30: Global in Vitro Diagnostics Market, by Geography, 2022-2031 (USD Million)
Figure 31: North America Market Snapshot
Figure 32: U.S. Market Snapshot
Figure 33: Canada Market Snapshot
Figure 34: Mexico Market Snapshot
Figure 35: Europe Market Snapshot
Figure 36: Germany Market Snapshot
Figure 37: UK Market Snapshot
Figure 38: France Market Snapshot
Figure 39: Italy Market Snapshot
Figure 40: Russia Market Snapshot
Figure 41: Spain Market Snapshot
Figure 42: Rest of Europe Market Snapshot
Figure 43: Asia-Pacific Market Snapshot
Figure 44: China Market Snapshot
Figure 45: India Market Snapshot
Figure 46: Japan Market Snapshot
Figure 47: Australia Market Snapshot
Figure 48: South Korea Market Snapshot
Figure 49: ASEAN Market Snapshot
Figure 50: Rest of Asia-Pacific Market Snapshot
Figure 51: MEA Market Snapshot
Figure 52: Turkey Market Snapshot
Figure 53: UAE Market Snapshot
Figure 54: Saudi Arabia Market Snapshot
Figure 55: South Africa Market Snapshot
Figure 56: Rest of MEA Market Snapshot
Figure 57: South America Market Snapshot
Figure 58: Brazil Market Snapshot
Figure 59: Argentina Market Snapshot
Figure 60: Rest of South America Market Snapshot
Figure 61: Company Market Ranking Analysis
Figure 62: Ace Matrix
Figure 63: Roche Holding AG - Company Insights
Figure 64: Roche Holding AG - Segment Breakdown
Figure 65: Roche Holding AG - SWOT Analysis
Figure 66: Thermo Fisher Scientific Inc. - Company Insights
Figure 67: Thermo Fisher Scientific Inc. - Segment Breakdown
Figure 68: Thermo Fisher Scientific Inc. - SWOT Analysis
Figure 69: Abbott Laboratories - Company Insights
Figure 70: Abbott Laboratories - Segment Breakdown
Figure 71: Abbott Laboratories - SWOT Analysis
Figure 72: Siemens Healthineers - Company Insights
Figure 73: Siemens Healthineers - Segment Breakdown
Figure 74: Siemens Healthineers - SWOT Analysis
Figure 75: Danaher Corporation - Company Insights
Figure 76: Danaher Corporation - Segment Breakdown
Figure 77: Danaher Corporation - SWOT Analysis
Figure 78: Bio-Rad Laboratories, Inc. - Company Insights
Figure 79: Bio-Rad Laboratories, Inc. - Segment Breakdown
Figure 80: Bio-Rad Laboratories, Inc. - SWOT Analysis
Figure 81: QIAGEN N.V. - Company Insights
Figure 82: QIAGEN N.V. - Segment Breakdown
Figure 83: QIAGEN N.V. - SWOT Analysis
Figure 84: Hologic, Inc. - Company Insights
Figure 85: Hologic, Inc. - Segment Breakdown
Figure 86: Hologic, Inc. - SWOT Analysis
Figure 87: Illumina, Inc. - Company Insights
Figure 88: Illumina, Inc. - Segment Breakdown
Figure 89: Illumina, Inc. - SWOT Analysis
Figure 90: Sysmex Corporation - Company Insights
Figure 91: Sysmex Corporation - Segment Breakdown
Figure 92: Sysmex Corporation - SWOT Analysis

Companies Mentioned

  • Roche Holding AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Siemens Healthineers
  • Danaher Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN N.V.
  • Hologic Inc.
  • Illumina Inc.
  • Sysmex Corporation